about
A Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites.Single-Nucleotide Polymorphisms Within MicroRNAs Sequences and Their 3' UTR Target Sites May Regulate Gene Expression in Gastrointestinal Tract Cancers.Genetic Variants of Cytochrome b-245, Alpha Polypeptide Gene and Premature Acute Myocardial Infarction Risk in an Iranian Population.In silico dissection of miRNA targetome polymorphisms and their role in regulating miRNA-mediated gene expression in esophageal cancer.Association of miR-146a rs2910164 and miR-149 rs2292832 Variants with Susceptibility to Type 2 Diabetes.Valproic acid may exerts its cytotoxic effect through rassf1a expression induction in acute myeloid leukemia.A novel mutation and variable phenotypic expression in a large consanguineous pedigree with Jalili syndrome.Copy Number Variants in Patients with Autism and Additional Clinical Features: Report of VIPR2 Duplication and a Novel Microduplication Syndrome.A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder.A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder.The pre-mir-27a variant rs895819 may contribute to type 2 diabetes mellitus susceptibility in an Iranian cohort.c.376G>A mutation in WFS1 gene causes Wolfram syndrome without deafness.Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes.Analysis of beta-hemolysis in human blood agars by Streptococcus pyogenesVariation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian populationThe clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancerGenotype-phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patientsThe effects of somatic mutations on EGFR interaction with anti-EGFR monoclonal antibodies: Implication for acquired resistance
P50
Q30383955-F3E05089-9BC7-4AEA-AB62-EDC9418BC0D9Q34197275-2593544B-2215-492C-933A-1FF26ADF6282Q37041329-884352C3-173F-486C-A6BA-90AADA289AD3Q38831897-743B93B6-7B53-44AD-97BF-BD9D62F972CAQ38977368-562AADCE-FBA0-4EBB-8BA8-674A33990657Q41915700-8F3F448B-A823-4B2F-95EA-7161D4742A61Q42696184-12E0AC1A-264D-429D-9B9C-41737C180376Q47962206-A066E766-38A4-4696-B84E-E3278516826FQ48037794-C3261A0C-68DD-420C-91F7-AC211A6A24BAQ50792441-3204B9DF-512C-496C-9658-25DEAFCFBA85Q51283235-69D7CE36-D957-4964-89B1-69CBFC5E431DQ51559893-066A21BC-1300-41FB-80B3-F48972DF5B59Q52665030-EAC0D109-9FDA-4D55-BF8E-E8BAE7D0720CQ61898791-31060E73-230B-4BA4-8162-B1A6B2789EA6Q85370313-68A2DF92-393F-4DE0-B64D-3339F440D9B9Q91255375-96516D2A-69C7-4B00-8EFB-29117AA20E1DQ91347627-854615A3-3DBF-445C-958A-AC485987ED4AQ92952318-D973C51C-B162-45DB-A8AF-2B0E3A8291F8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hamid Ghaedi
@ast
Hamid Ghaedi
@en
Hamid Ghaedi
@es
Hamid Ghaedi
@nl
Hamid Ghaedi
@sl
type
label
Hamid Ghaedi
@ast
Hamid Ghaedi
@en
Hamid Ghaedi
@es
Hamid Ghaedi
@nl
Hamid Ghaedi
@sl
prefLabel
Hamid Ghaedi
@ast
Hamid Ghaedi
@en
Hamid Ghaedi
@es
Hamid Ghaedi
@nl
Hamid Ghaedi
@sl
P106
P1153
56303242500
P31
P496
0000-0002-5034-0586